Thanks, certainly not that positive and the trend is not in ACRs...

Thanks, certainly not that positive and the trend is not in ACRs favour at this point.  But not disastrous either... I don't see the market collapsing (yet) like some are already calling... those counting milestones for this calendar year or the next, at this point are dreaming... but at some point in the future they may hit the target - that is US220m on GLOBAL net sales... for this to stack up and have upside on current market pricing all we need is stable US market prescription growth with pricing to hold and some international expansion... admittedly ex US net sales are still some way off in terms of magnitude - they are growing rapidly and at some point may get ACR over the line here?  Assuming generics do not destroy market pricing like some are saying....